TrialHeart and vessels2019

Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.

Satoshi Imaizumi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.